Bit's upcoming conferences
  • A Plenary Forum from a Panel of Leading Experts in Cancer Field
  • 400+ Oral Presentations on Hear and Discuss the Most Exciting Research Discoveries in Cancer Field
  • Network with Senior Scientists, Executives and Others over 70 Scientific and Business Sessions
  • Look for a Job, Fellowship, Postdoctoral Position, or New Collaborator
  • Visit over 100 Commercial and Nonprofit Exhibits Offering New Products and Services Exhibiters
  • Post Tech Tours to Famous Science Spots & Historical Sites in Nanjing


Dr. Bruno Osterwalder, Senior VP, Senior Strategic Advisor Oncology, Global Drug Development & Medical (GDM), Merck Serono, Switzerland


Dr. Alan Garen, Professor, Yale University, USA


Dr. Juergen Engel, Chairman of the advisory board of ElexoPharm GmbH, Germany


 Dr. Rajesh C. Shrotriya, CEO, Spectrum Pharmaceuticals, Inc, Canada



Dr. Irving Taylor,  Professor & Vice-Dean , UCL Medical School, UK

Dr. Xin-Yuan Liu, Member of Chinese Academy of Sciences, Institute of Biochemistry and Cell Biology; Professor, College of Life Science, Zhejiang Sci-Tech University, China




Dr. Tursz Thomas, Professor, Institute Gustave-Roussy, France

说明: Peter Selby

Dr. Peter Selby, President of the Association of Cancer Physicians; Director of the Leeds Institute of Molecular Medicine, St James's University Hospital, UK


Dr. M.V.Pillai, Professor, Kimmel Cancer Centre, Thomas Jefferson University, USA

Dr. Caifu Chen, Vice President, Life Technologies Corporation, USA

Dr. Russel J. Reiter, Professor, The University of Texas Health Science Center, USA

55 Markland BCTR.jpg

Dr. Francis S. Markland, Professor, Keck School of Medicine, University of Southern California, Los Angeles, USA


 Dr. Thaddeus Bartter, Professor & Director, University of Arkansas for Medical Sciences, USA

Dr. Linda Eagen, President & CEO, Ottawa Regional Cancer Foundation, Canada




Dr. Richard Justin Davies, Director, University of Cambridge, UK

Dr. Orjan Hallberg, Director, Hallberg Independent Research, Sweden


Dr. Shi Wei, Associate Professor & Medical Director, The University of Alabama at Birmingham & Immunohistochemistry Laboratory, UAB Hospital, USA

Dr. Carolyn Sue Richards, Professor, Oregon Health & Science University, USA

Dr. Jerzy Klijanienko, Professor, Department of Pathology, Institute Curie, France

Dr. Gilbert C Faure, Professor, University of Lorraine, France


Dr. Yuan-Soon Ho , Professor & Chairman, Translational Cancer Research Center, Graduate Institute of Biomedical Technology, Taipei Medical University, Taiwan

Dr. King-Thom Chung, Professor, The University of Memphis, USA


Dr. Zhe-Sheng (Jason) Chen, Professor, College of Pharmacy and Health Sciences, St. John's University, USA

Dr. Robert Rees, Director, The John van Geest Cancer Research Centre, Nottingham Trent University, UK


Dr. Yanping Zhang, Professor, The University of North Carolina at Chapel Hill, USA

Dr. Syed Raza Ahmed, World Wide Director, Medical Affairs – Self Administration Injection Systems, Becton, Dickinson & Company;BD Medical, USA


Please Click here to Download.

The 6th Annual World Cancer Congress (WCC-2013) was successfully held on May 23-25, 2013 in Xi'an, China, with a theme of A New Era in Cancer Research and Therapy. More than 400 participants from over 40 countries and areas have attended the WCC-2013.

As the keynote speakers, Dr. Jean-Pierre ARMAND, Senior Consultant Advisor, Institute Gustave Roussy, France; Dr. Bruno Osterwalder, Senior Vice President, Senior Strategic Advisor Oncology, Merck Serono Darmstadt, Switzerland; Dr. Yan Sun, Member of Chinese Academy of Engineering; Director, National GCP Center for Anticancer Agents, Cancer Hospital/Institute, CAMS &PUMC, China; Dr. Xin-Yuan Liu, Member of Chinese Academy of Sciences, Institute of Biochemistry and Cell Biology; Professor, College of Life Science, Zhejiang Sci-Tech University, China attended the opening ceremony and the Keynote Forum.

Depending on the warmly support and good suggestions from all of the participants, we are definitely sure BIT's 7th World Cancer Congress-2014, will be better and more successful than WCC-2013!

As part of the 2014 World Cancer Congress, an exhibition space will provide a unique opportunity for exhibitors to showcase their products and services to participants with interests in all areas of cancer. Developed to offer comfort to delegates while maximizing exhibitor exposure, the coffee breaks and poster sessions will all take place in the exhibition area promoting frequent and repeated opportunities for delegates to visit the exhibits.

Exhibitors' advantages

The exhibition will be visited by participants of the conference it means by your authentic target    group from China and other countries.
The exhibitors have the opportunity to present their exhibits more detailed, and have the    opportunity for longer discussion with inquiring visitors – in most cases specialists – than    during session discussions.
Exhibition Date:
Set-up date: May 15, 2014
Show dates: May 16-18, 2014 09:00-18:00
Place: Nanjing, China
Space: 3 m (W) x 3 m (D) x 2.5 m (H)
>> Click to see larger view

News Released
Hosting Organizations
Information Research Center of International Talent, SAFEA
CCPIT Nanjing Sub-Council
The Second Affiliated Hospital of Nanjing Medical University
Operating Organizations
BIT Congress Inc.
Foreign Experts Databank of SAFEA-Dalian Branch
Official Travel Agency
BIT World Travel Service, Inc.
Cooperation Exhibition

The All China Biotech Conference & Exhibition
Concurrent Conferences

BIT's 5<sup>th</sup> Annual World Congress of Neurotalk-2014

BIT's 5th Annual World Congress of Neurotalk-2014 (Neurotalk2014)

BIT's 1st Annual World Congress of
High-Tech Acupuncture & Integrative Medicine 2014
Media Partners

© 2013-2014 All right reserved by BIT Congress Inc.
Contact Us: Tel: 0086-411-84799609, Fax: 0086-411-84796897